The oncogene AEG-1 shows promise as a target for managing chemotherapy-induced peripheral neuropathy, according to a recently ...

Cancer treatment often involves powerful drugs that can damage the nerves, resulting in chemotherapy-induced peripheral neuropathy (CIPN). Although any type of cancer treatment can cause neuropathy, ...

The CIPN treatment market is poised for growth driven by personalized multimodal care, digital health innovations, and ...

Please provide your email address to receive an email when new articles are posted on . Chemotherapy-induced peripheral neuropathy is a potentially debilitating, often persistent adverse event ...

Q: I have peripheral neuropathy following chemotherapy. Is there anything I can do to alleviate my symptoms? A: Chemotherapy-induced peripheral neuropathy is a set of symptoms caused by damage to ...

Dr. Sharon Gurm, BSc. ND, FABNO, Naturopathic Oncologist, Port Moody, BC discusses how a naturopathic oncologist can help treat chemotherapy-induced peripheral neuropathy. Trump says U.S. will ...

There are few precise measures of how many cancer patients deal with chemotherapy-induced peripheral neuropathy, or CIPN, but the scope of the problem is clearly enormous. Scottish researchers ...

The randomized clinical trial found that exercise training reduced the onset of chemotherapy-induced peripheral neuropathy (CIPN) by 50 to 70 percent, depending on the type of chemo used.

Dublin, July 14, 2022 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel ...

“When one hears peripheral neuropathy ... neuropathy – perhaps the most heartbreaking form is chemotherapy-induced peripheral neuropathy (CIPN) and it’s heartbreaking because it often ...

New York, July 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global ...

Neuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 in JAMA Internal Medicine. Fiona Streckmann, Ph.D., from ...